Skip to main content
Clinical Cardiology logoLink to Clinical Cardiology
. 2009 Feb 3;22(1):13–16. doi: 10.1002/clc.4960220107

The role of cardiac Troponin‐I (cTnI) in risk stratification of patients with unstable coronary artery disease

Milenko J Tanasijevic 1,, Christopher P Cannon 2, Elliott M Antman 2
PMCID: PMC6655707  PMID: 9929748

Abstract

In patients with chest pain at rest but no ST‐segment elevation on the electrocardiogram, the diagnoses of unstable angina and non‐Q‐wave myocardial infarction (MI) are usually considered together because they cannot be differentiated clinically or angiographically. Since the extent of myocardial necrosis is an important determinant of the risk of death, it is important to identify serum markers with which to predict prognosis, in order to initiate appropriate medical treatment and/or invasive procedures in these patients. Cardiac troponin‐I (cTnI), one of the subunits of the troponin regulatory complex, binds to actin and inhibits interactions between actin and myosin. The presence of elevated cTnI in serum is a significant prognostic indicator in patients with unstable angina and non‐Q wave MI. Its independent prognostic potential persists even after adjustment for independent baseline variables known to be significantly associated with an increased risk of cardiac events. The use of cTnI in the triage of patients with unstable coronary disease may identify those at greater risk for adverse cardiac events.

Keywords: cardiac troponin‐I (cTnI), cardiac troponin‐T, creatine kinase‐MB (CK‐MB), risk stratification, myocardial infarction, unstable angina, non‐Q‐wave myocardial infarction

Full Text

The Full Text of this article is available as a PDF (467.8 KB).

References

  • 1. Cannon CP: Improved management of unstable angina and non‐Q‐wave MI. Contemp Intern Med 1995; 7: 11–24 [PubMed] [Google Scholar]
  • 2. Falk E: Unstable angina with fatal outcome: Dynamic coronary thrombosis leading to infarction and/or sudden death: Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation 1985; 71: 699–708 [DOI] [PubMed] [Google Scholar]
  • 3. Geltman EM, Ehsani AA, Campbell MK, Schechtman K, Roberts R, Sobel BE: The influence of location and extent of myocardial infarction on long‐term ventricular dysrhythmia and mortality. Circulation 1979; 60: 805–814 [DOI] [PubMed] [Google Scholar]
  • 4. Cannon CP, McCabe CH, Stone PH, Rogers WJ, Schactman M, Thompson BW, Pearce DJ, Diver DJ, Kells C, Feldman T, Williams M, Gibson RS, Kronenberg MW, Ganz LI, Anderson HV, Braunwald E, for the TIMI III Registry ECG Ancillary Study Investigators : The electrocardiogram predicts one‐year outcome of patients with unstable angina and non‐Q‐wave myocardial infarction: Results of the TIMI III Registry Ancillary Study. J Am Coll Cardiol 1997; 30: 133–140 [DOI] [PubMed] [Google Scholar]
  • 5. Fuster V, Badimon L, Badimon JJ, Chesebro JH: The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992; 326: 242–250, 310–318 [DOI] [PubMed] [Google Scholar]
  • 6. Bodor GS: Cardiac troponin‐I: A highly specific biochemical marker for myocardial infarction. J Clin Immunoassay 1994; 17: 40–44 [Google Scholar]
  • 7. Bodor GS, Porterfield D, Voss EM, Smith S, Apple FS: Cardiac troponin‐I is not expressed in fetal and healthy or diseased adult human skeletal muscle tissue. Clin Chem 1995; 41: 1710–1715 [PubMed] [Google Scholar]
  • 8. McLaurin MD, Apple FS, Voss EM, Herzog CA, Sharkey SW: Cardiac troponin I, cardiac troponin T, and creatine kinase MB in dialysis patients without ischemic heart disease: Evidence of cardiac troponin T expression in skeletal muscle. Clin Chem 1997; 43: 976–982 [PubMed] [Google Scholar]
  • 9. Adams JE III, Schechtman KB, Landt Y, Ladenson JH, Jaffe AS: Comparable detection of acute myocardial infarction by creatine kinase MB isoenzyme and cardiac troponin I. Clin Chem 1994; 40: 1291–1295 [PubMed] [Google Scholar]
  • 10. Antman EM, Tanasijevic MJ, Thompson B, Schactman M, McCabe CH, Cannon CP, Fischer GA, Fung AY, Thompson C, Wybenga D, Braunwald E: Cardiac‐specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996; 335: 1342–1349 [DOI] [PubMed] [Google Scholar]
  • 11. Galvani M, Ottani F, Ferrini D, Ladenson JH, Destro A, Baccos D, Jaffe AS: Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina. Circulation 1997; 95: 2053–2059 [DOI] [PubMed] [Google Scholar]
  • 12. Luscher MS, Thygesen K, Ravkilde J, Heickendorff L, for the TRIM Study Group : Applicability of cardiac troponin T and I for early risk stratification in unstable coronary artery disease. Circulation 1997; 96: 2578–2585 [DOI] [PubMed] [Google Scholar]
  • 13. Bodor GS, Porter S, Landt Y, Ladenson JH: Development of monoclonal antibodies for an assay of cardiac troponin I and preliminary results in suspected cases of myocardial infarction. Clin Chem 1992; 38: 2203–2241 [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES